![Anna French](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna French
Directeur/Membre du Conseil chez
WindMIL Therapeutics, Inc.
Profil
Anna French currently works at Cardialen, Inc., as Director, WindMIL Therapeutics, Inc., as Director from 2018, Auron Therapeutics, Inc., as Director from 2020, Jasper Tx Corp., as Director from 2019, Umoja Biopharma, Inc., as Director from 2020, Paros Bio, Inc., as Director, Entact Bio, Inc., as Director, and Qiming US Ventures Management, LLC, as Managing Partner from 2017.
Dr. French also formerly worked at Jasper Therapeutics, Inc., as Independent Director from 2019 to 2024.
Dr. French received her graduate degree from the University of Oxford and undergraduate degree from the University of Bristol.
Postes actifs de Anna French
| Sociétés | Poste | Début |
|---|---|---|
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Private Equity Investor | 01/01/2017 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Directeur/Membre du Conseil | 01/06/2018 |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Directeur/Membre du Conseil | 01/08/2020 |
Jasper Tx Corp.
 Jasper Tx Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Directeur/Membre du Conseil | 01/01/2019 |
Auron Therapeutics, Inc.
 Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Directeur/Membre du Conseil | 01/12/2020 |
Cardialen, Inc.
 Cardialen, Inc. Medical SpecialtiesHealth Technology Develops low-energy defibrillation and cardio version therapy designed to treat atrial fibrillation and ventricular tachycardia | Directeur/Membre du Conseil | - |
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Directeur/Membre du Conseil | - |
Entact Bio, Inc.
 Entact Bio, Inc. BiotechnologyHealth Technology Develops medicines for increasing protein function | Directeur/Membre du Conseil | - |
Anciens postes connus de Anna French
| Sociétés | Poste | Fin |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/06/2024 |
Formation de Anna French
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Develops low-energy defibrillation and cardio version therapy designed to treat atrial fibrillation and ventricular tachycardia | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Commercial Services |
Jasper Tx Corp.
Jasper Tx Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Health Technology |
Entact Bio, Inc.
Entact Bio, Inc. BiotechnologyHealth Technology Develops medicines for increasing protein function | Health Technology |
Choisissez Zonebourse 
